Recent Finacing
Recent Raise
TearSolutions is a biotechnology company developing proprietary lacritin peptide proteoforms, including Lacripep, to restore tear-film layers and corneal health for ocular surface diseases under an exclusive UVA license.
Focus Areas
Total Raised
Funding round
See the team members at TearSolutions.
